Illumina, Inc.
$139.07
$0.30(-0.22%)
Illumina, Inc.
ILMN
$139.07
$0.30(-0.22%)
Illumina, Inc.
ILMN
NASDAQ
$139.07
$0.30(-0.22%)
Chart
Upcoming Earnings
Next report date
Jul 30, 2026
Report period
Q3 2026
EPS Estimate
$1.24
Revenue Estimate
$1.12B
Key stats
52-Week Range$139.07
$73.86
$155.53
Market capitalization
$21.13BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
24.35Basic EPS (TTM)
$5.47Net income (TTM)
$850.00MRevenue (TTM)
$4.34BAvg. volume
1.80MBeta (1Y)
1.49Employees
8.97KMarket capitalization
$21.13BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
24.35Basic EPS (TTM)
$5.47Net income (TTM)
$850.00MRevenue (TTM)
$4.34BAvg. volume
1.80MBeta (1Y)
1.49Employees
8.97KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Illumina, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jacob Thaysen
Website
www.illumina.comHeadquarters
5200 Illumina Way, San Diego, CA, 92122
IPO Date
2000-07-28
Identifiers
ISIN
US4523271090Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services...
Related Stocks
$309.97
1D:
3.3%
1Y:
46.9%
US9553061055Healthcare
Mkt Cap
$21.90B
P/E Ratio TTM
39.9
Revenue TTM
$3.22B
Beta
1.15
Earnings TTM
$542.70M
Dividend Yield TTM
0.29%
$257.14
1D:
1.6%
1Y:
4.2%
US5049221055Healthcare
Mkt Cap
$21.16B
P/E Ratio TTM
22.4
Revenue TTM
$13.95B
Beta
0.99
Earnings TTM
$876.50M
Dividend Yield TTM
1.13%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate